FDA Inspection 1158875 — Royal Biologics, Inc.
The FDA completed an inspection of Royal Biologics, Inc. on Nov 16, 2021 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hackensack, NJ (United States)